Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s Disease

Published:2021-03-31 Issue:8 Volume:58 Page:3641-3652
ISSN:0893-7648
Container-title:Molecular Neurobiology
language:en
Short-container-title:Mol Neurobiol

Author:

Puentes Laura N.,Lengyel-Zhand Zsofia,Reilly Sean W.,Mach Robert H.^ORCID

Funder

Michael J. Fox Foundation for Parkinson's Research

National Institute of Neurological Disorders and Stroke

National Institute of General Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Neuroscience (miscellaneous),Cellular and Molecular Neuroscience,Neurology

Link

https://link.springer.com/content/pdf/10.1007/s12035-021-02371-4.pdf

Reference39 articles.

1. Deshmukh D, Qiu Y (2015) Role of PARP-1 in prostate cancer. Am J Clin Exp Urol 3(1):1–12

2. Ba X, Garg NJ (2011) Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases. Am J Pathol 178(3):946–955

3. Rosado MM, Bennici E, Novelli F, Pioli C (2013) Beyond DNA repair, the immunological role of PARP-1 and its siblings. Immunology 139(4):428–437

4. Wei W, Li Y, Lv S, Zhang C, Tian Y (2016) PARP-1 may be involved in angiogenesis in epithelial ovarian cancer. Oncol Lett 12(6):4561–4567

5. Malapetsa A, Noe AJ, Poirier GG, Desnoyers S, Berger NA, Panasci LC (1996) Identification of a 116 kDa protein able to bind 1,3-bis(2-chloroethyl)-1-nitrosourea-damaged DNA as poly(ADP-ribose) polymerase. Mutat Res 362(1):41–50

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases;ACS Chemical Neuroscience;2024-04-22

2. Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs;Molecular Neurobiology;2024-03-26

3. Strategies for translating proteomics discoveries into drug discovery for dementia;Neural Regeneration Research;2024-01

4. The 3Ranker: An AI-based Algorithm for Finding Non-animal Alternative Methods;Alternatives to Laboratory Animals;2023-10-21

5. Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities;Neurobiology of Disease;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3